O'Neill,CB , Atoria,CL , O'Reilly,EM , La Femina,J , Henman,MC , Elkin,EB, 2012.Costs and trends in pancreatic cancer treatment,Cancer 118 5132 -9
KhoranaAA,ManguPB,BerlinJ,EngebretsonA,HongTS,MaitraA, 2016.Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline,J Clin Oncol 31 -
FeigBW,ChingCD, 2012.The MD Anderson surgical oncology handbook, 472 -90
MartinLK,LuuDC,LiX,MuscarellaP,EllisonEC,BloomstonM, 2014.The addition of radiation to chemotherapy does not improve outcome when compared to chemotherapy in the treatment of resected pancreas cancer: the results of a singleinstitution experience,Ann Surg Oncol 21 862 -7
2016.National comprehensive cancer network. NCCN clinical practice guidelines in oncology,Pancreatic adenocarcinoma, v.2 -
NeoptolemosJ,PalmerD,GhanehP,ValleJW,CunninghamD,WadsleyJ, 2016.ESPAC-4: A multicenter, international, open label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP), versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma,Pancreatology 16 S63 -
NeoptolemosJ,BüchlerM,StockenDD,GhanehP,SmithD, 2009.: A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/ folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma,J Clinical Oncol 27 LBA4505 -
ZahirMN,JabbarAA, 2015.Metastatic pancreatic carcinoma and experience with FOLFIRINOX - a cross-sectional analysis from a developing country,Asian Pac J Cancer Prev 16 6001 -6
SiegelR,NaishadhamD,JemalA, 2013.,CA Cancer J Clin 63 11 -30
EdgesSB,ComptonCC, 2010.The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM,Ann Surg Oncol 17 1471 -4
GongJ,TuliR,ShindeA,HendifarAE, 2016.Meta-analyses of treatment standards for pancreatic cancer,Mol Clin Oncol 4 315 -25
RaiganiS,AmmoriJ,KimJ,HardacreJM, 2014.Trends in the treatment of resectable pancreatic adenocarcinoma,J Gastrointest Surg 18 113 -23
MillerRC,LottMJ,CorsiniMM, 2009.Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from mayo clinic for the 5th JUCTS symposium,Int J Radiat Oncol Biol Phys 75 364 -8
StathisA,Moore MJ, 2010.Advanced pancreatic carcinoma: current treatment and future challenges,Nat Rev Clin Oncol 7 163 -72
AhmadZ,MinhasK,MoeenS,AhmedA, 2015.Epidemiologic data, tumor size, histologic tumor type and grade, pathologic staging and follow-up in cancers of the ampullary region and head of pancreas in 311 Whipple resection specimens of Pakistani patients,Asian Pac J Cancer Prev 16 7541 -6
YuZ,ZhongW,TanZM,WangLY,YuanYH, 2015.Gemcitabine adjuvant therapy for resected pancreatic cancer, A meta-analysis,Am J Clin Oncol 38 322 -5
WolfgangCL,HermanJM,LaheruDA,KleinAP,ErdekMA,FishmanEK, 2013.Recent progress in pancreatic cancer,CA Cancer J Clin 63 318 -48
BayraktarS,BayraktarUD,Rocha-LimaCM, 2010.Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer,World J Gastroenterol 16 673 -82
LiaoWC,ChienKL,LinYL,WuMS,LinJT,WangHP, 2013.Adjuvant treatments for resected pancreatic adenocarcinoma, A systematic review and network meta-analysis,Lancet Oncol 14 1095 -103